Novel Diagnostic and Therapeutic Approaches to Urologic Oncology
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Clinical Medicine, Cell, and Organism Physiology".
Deadline for manuscript submissions: 25 August 2024 | Viewed by 186
Special Issue Editors
2. Faculty of Medicine, “Carol Davila” University of Medicine and Pharmacy, 050474 Bucharest, Romania
Interests: endourology; basic research on the diagnosis of benign prostatic hyperplasia and prostate cancer; urolithiasis; uro-oncology
2. Faculty of Medicine, “Carol Davila” University of Medicine and Pharmacy, 050474 Bucharest, Romania
Interests: endourology; benign prostatic hyperplasia; urolithiasis; uro-oncology
Interests: uro-oncology; robotic urology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Urologic oncology is one of the most dynamic fields of medicine, with research focused on various fronts, including improvements in developing new tumor markers with increasing roles in early diagnosis and tumor staging. New imaging protocols for prostate cancer and bladder cancer, along with novel chemotherapy regimens and the advancement of targeted and personalized therapies such as immunotherapy and genetic approaches, have led to unprecedented public interest in this field.
In this Special Issue, we hope to present the latest discoveries in this field, and welcome submissions that discuss diagnostic or therapeutic strategies in early and advanced urologic oncology, focusing on prostate cancer, bladder cancer, upper urinary tract tumors, renal tumors, testicular or penile cancer, and urethral cancer.
Dr. Cosmin-Victor Ene
Prof. Dr. Bogdan Florin Geavlete
Dr. Cristian I. Surcel
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- diagnosis
- therapy
- up-to-date
- uro-oncologic pathology
